As aerobic glycolysis is maintained, oncogenes are activated, notably Kirsten rat sarcoma (KRAS) and MYC, and tumour suppressor genes, such as TP53, are inactivated, which together modulates several biosynthetic pathways to sustain tumour growth [135,139]. The gene discussed is MYC; the disease is neoplasm.